Incidence of Acute Kidney Injury Among Patients Receiving the Combination of Vancomycin with Piperacillin-Tazobactam or Meropenem.

Abstract:

INTRODUCTION:Vancomycin (VAN) is associated with an increased risk of acute kidney injury (AKI). Evidence is conflicting regarding the risk of AKI when VAN is combined with an antipseudomonal β-lactam. OBJECTIVES:To determine the comparative incidence of AKI when VAN is combined with piperacillin-tazobactam (PTZ) or meropenem (MER). METHODS:This was a retrospective cohort study of acutely ill adults receiving the combination of VAN and PTZ or MER for at least 48 hours between November 1, 2014, and October 31, 2016, in a tertiary care hospital. Critically ill patients and those with baseline renal dysfunction were excluded. The primary outcome was the incidence of AKI during or within 72 hours of completing antibiotic therapy, defined as an absolute increase in serum creatinine (Scr ) of 0.5 mg/dl or higher or a 50% or more increase in Scr from baseline. Secondary outcomes included time to AKI development, duration of AKI, and length of hospitalization. Continuous variables were assessed using the Wilcoxon rank sum or the Student t test; categorical variables were assessed using χ2 or Fisher exact tests. Independent risk factors for the development of AKI were also examined. RESULTS:A total of 169 patients were evaluated. A significantly higher incidence of AKI was observed in the PTZ group compared with MER (16.5% vs 3.6%; p=0.009). The median time to AKI onset was significantly shorter with PTZ compared with MER (3 vs 7 days; p=0.009). After adjusting for baseline differences, VAN/PTZ was associated with a 6.8-fold increased risk of developing AKI (odds ratio [OR] 6.8, 95% confidence interval [CI] 1.5-30.9) compared with VAN/MER. VAN doses higher than 4 g/day and trough levels higher than 20 μg/ml were independent risk factors for developing AKI (OR 8.7, 95% CI 1.04-72.94, and OR 9.01, 95% CI 1.44-56.21, respectively). CONCLUSION:The combination of VAN/PTZ increases the risk of AKI when compared with VAN/MER in acutely ill adults.

journal_name

Pharmacotherapy

journal_title

Pharmacotherapy

authors

Robertson AD,Li C,Hammond DA,Dickey TA

doi

10.1002/phar.2179

subject

Has Abstract

pub_date

2018-12-01 00:00:00

pages

1184-1193

issue

12

eissn

0277-0008

issn

1875-9114

journal_volume

38

pub_type

杂志文章
  • Evaluation of a Once/Day Tobramycin Regimen to Achieve Target Concentrations in Adult Patients with Cystic Fibrosis.

    abstract:STUDY OBJECTIVE:To evaluate the success of an initial tobramycin dosing regimen to achieve target peak and trough concentrations in adult patients with pulmonary exacerbations of cystic fibrosis (CF). DESIGN:Retrospective single-center medical record review. SETTING:Large tertiary care academic medical center. PATIE...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1002/phar.1762

    authors: Staubes BA,Metzger NL,Walker SD,Peasah SK

    更新日期:2016-06-01 00:00:00

  • Resistance to antimicrobial agents: an update.

    abstract::Decades of overuse and misuse of antibiotics have turned the resistance problem into a crisis. Preventive and corrective measures are urgently needed. This article presents a broad overview of the status of antimicrobial resistance. Resistance in key bacterial pathogens such as enterococci, staphylococci, pneumococci,...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1592/phco.24.18.203S.52236

    authors: Rybak MJ

    更新日期:2004-12-01 00:00:00

  • Alteplase for Acute Ischemic Stroke after Heparin Reversal with Protamine: A Case Report and Review.

    abstract::Few patients presenting with acute ischemic stroke (AIS) are eligible for alteplase, especially those receiving ongoing anticoagulation. We describe the first reported case of a patient receiving full-dose intravenous (IV) alteplase for AIS after heparin reversal with protamine. A 73-year-old man presented with AIS. H...

    journal_title:Pharmacotherapy

    pub_type:

    doi:10.1002/phar.1997

    authors: Fontaine GV,Smith SM

    更新日期:2017-10-01 00:00:00

  • Treatment of extensively drug-resistant tuberculosis and role of the pharmacist.

    abstract::Abstract Outbreaks of extensively drug-resistant tuberculosis (XDR-TB) in developing countries and recent headlines of an American traveling with a resistant variant of tuberculosis have brought XDR-TB into the spotlight. The World Health Organization and the United States Centers for Disease Control and Prevention ha...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1592/phco.28.10.1243

    authors: Mitrzyk BM

    更新日期:2008-10-01 00:00:00

  • More stable and reliable pharmacokinetics with preprandial administration of cyclosporine compared with postprandial administration in patients with refractory nephrotic syndrome.

    abstract:STUDY OBJECTIVE:To compare the absorption profile of cyclosporine after preprandial administration with that after postprandial administration, and to determine which administration time resulted in a more stable absorption profile and the timing of the drug concentration that was the most reliable marker for monitorin...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.25.1.52.55617

    authors: Kusaba T,Konno Y,Hatta S,Fujino T,Yasuda T,Miura H,Sasaki H,Okabayashi J,Murao M,Sakurada T,Imai G,Shirai S,Kuboshima S,Shima Y,Ogimoto G,Sato T,Masuhara K,Kimura K

    更新日期:2005-01-01 00:00:00

  • Dalbavancin and Oritavancin: An Innovative Approach to the Treatment of Gram-Positive Infections.

    abstract::Health care-associated infections, especially those caused by multidrug-resistant gram-positive organisms, such as methicillin-resistant Staphylococcus aureus (MRSA), are a growing public health threat. In 2014, the U.S. Food and Drug Administration approved two new lipoglycopeptides, oritavancin and dalbavancin, for ...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1002/phar.1641

    authors: Roberts KD,Sulaiman RM,Rybak MJ

    更新日期:2015-10-01 00:00:00

  • Pharmacologic options for reducing the shivering response to therapeutic hypothermia.

    abstract::Recent literature has demonstrated significant improvements in neurologic outcomes in patients who have received induced hypothermia in the setting of out-of-hospital cardiac arrest. Through multiple metabolic mechanisms, the induction of hypothermia slows the progression and devastation of transient cerebral hypoxia....

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1592/phco.30.8.830

    authors: Weant KA,Martin JE,Humphries RL,Cook AM

    更新日期:2010-08-01 00:00:00

  • Effectiveness of pharmacist-administered diabetes mellitus education and management services.

    abstract:STUDY OBJECTIVES:To evaluate the effectiveness of pharmacist-administered diabetes mellitus education and management services on selected diabetes performance measures. Additional goals were to compare outcomes with goals specified for patients with diabetes by the National Committee for Quality Assurance (NCQA) and id...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,多中心研究

    doi:10.1592/phco.2005.25.12.1809

    authors: Ragucci KR,Fermo JD,Wessell AM,Chumney EC

    更新日期:2005-12-01 00:00:00

  • Determination of fluoxetine and norfluoxetine concentrations in cadaveric allograft skin.

    abstract::Fluoxetine hydrochloride is the sixth most prescribed drug in the United States and is administered to treat major depression. A cadaveric skin donation was obtained from a 46-year-old woman who died as a result of a fluoxetine overdose. Due to the potential penetration of the drug and its major metabolite, norfluoxet...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:

    authors: Neudeck BL,Taddonio TE,Garner WL,Welage LS

    更新日期:1998-07-01 00:00:00

  • Role of the pharmacist.

    abstract::The prevalence of cardiovascular risk factors continues to rise, with considerable emphasis on the upward trends in obesity and diabetes mellitus, which have increased by 46% and 60%, respectively, in the past 10 years. The alarming increase in the prevalence of diabetes and obesity has resulted in the development of ...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.26.12part2.227S

    authors: Bottorff M

    更新日期:2006-12-01 00:00:00

  • Combination carbapenem-sulbactam therapy for critically ill patients with multidrug-resistant Acinetobacter baumannii bacteremia: four case reports and an in vitro combination synergy study.

    abstract::Infections caused by multidrug-resistant Acinetobacter baumannii have become a therapeutic challenge for clinicians worldwide. Although colistin and tigecycline have been successful in treating patients with these infections, these agents are not available on a worldwide basis. We describe four critically ill patients...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.27.11.1506

    authors: Lee NY,Wang CL,Chuang YC,Yu WL,Lee HC,Chang CM,Wang LR,Ko WC

    更新日期:2007-11-01 00:00:00

  • Illicit use of specific prescription stimulants among college students: prevalence, motives, and routes of administration.

    abstract:OBJECTIVES:To explore the illicit use of specific prescription stimulants among college students and add to our understanding of reasons (motives) and routes of administration associated with illicit use of these drugs. METHODS:A random sample of 4580 college students self-administered a Web-based survey. The survey c...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.26.10.1501

    authors: Teter CJ,McCabe SE,LaGrange K,Cranford JA,Boyd CJ

    更新日期:2006-10-01 00:00:00

  • Enoxaparin-associated retroperitoneal bleeding in two patients with renal insufficiency.

    abstract::Two patients with chronic kidney disease experienced a major bleeding event, retroperitoneal hematoma, requiring a blood transfusion after the administration of enoxaparin. The first patient was a 61-year-old Caucasian woman with multiple comorbidities, including chronic kidney disease stage 4. She received subcutaneo...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.25.5.769.63596

    authors: Malik A,Capling R,Bastani B

    更新日期:2005-05-01 00:00:00

  • Bacterial resistance to beta-lactams, and its prevention with combination antimicrobial therapy.

    abstract::The clinical and economic impacts of bacterial resistance are substantial. The development of bacterial resistance during a course of therapy often leads to clinical failure, prolonged hospitalization, increased morbidity, mortality, and increased health care costs. Resistance has been reported to occur most frequentl...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:

    authors: Barriere SL

    更新日期:1992-01-01 00:00:00

  • Pharmacokinetics of daptomycin in a critically ill adolescent with vancomycin-resistant enterococcal endocarditis.

    abstract::Daptomycin is a lipopeptide antibiotic active against multidrug-resistant gram-positive organisms. Our search of the literature found no published pediatric pharmacokinetic data. We report the use of pharmacokinetic analysis of daptomycin in a 13-year-old boy with vancomycin-resistant Enterococcus faecium endocarditis...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.26.5.694

    authors: Akins RL,Haase MR,Levy EN

    更新日期:2006-05-01 00:00:00

  • Physician-pharmacist comanagement of hypertension: a randomized, comparative trial.

    abstract:OBJECTIVE:To compare the effectiveness of an evidence-based, systematic approach to hypertension care involving comanagement of patients by primary care physicians and clinical pharmacists versus usual care in reducing blood pressure in patients with uncontrolled hypertension. METHODS:Patients in a staff model medical...

    journal_title:Pharmacotherapy

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1592/phco.23.2.209.32096

    authors: Borenstein JE,Graber G,Saltiel E,Wallace J,Ryu S,Archi J,Deutsch S,Weingarten SR

    更新日期:2003-02-01 00:00:00

  • Active transport of nitrofurantoin into human milk.

    abstract:STUDY OBJECTIVE:To determine the extent to which nitrofurantoin is transferred into human milk. DESIGN:Prospective, single-dose pharmacokinetic study. SETTING:University-affiliated clinical research center. PATIENTS:Four healthy lactating women 8-26 weeks postpartum. INTERVENTION:All subjects received a single, ora...

    journal_title:Pharmacotherapy

    pub_type: 临床试验,杂志文章

    doi:10.1592/phco.21.7.669.34574

    authors: Gerk PM,Kuhn RJ,Desai NS,McNamara PJ

    更新日期:2001-06-01 00:00:00

  • Effects of perioperative antiinflammatory and immunomodulating therapy on surgical wound healing.

    abstract::Patients with various rheumatologic and inflammatory disease states commonly require drugs known to decrease the inflammatory or autoimmune response for adequate control of their condition. Such drugs include nonsteroidal antiinflammatory drugs (NSAIDs), cyclooxygenase (COX)-2 inhibitors, corticosteroids, disease-modi...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1592/phco.2005.25.11.1566

    authors: Busti AJ,Hooper JS,Amaya CJ,Kazi S

    更新日期:2005-11-01 00:00:00

  • Allopurinol for the Treatment of Refractory Aggression: A Case Series.

    abstract:OBJECTIVE:Allopurinol is a drug indicated for the treatment and prevention of gout. Through various theorized mechanisms, there has been an observed benefit in reducing aggression in patients with dementia who are refractory to traditional interventions. This case series of eight patients reports the use of allopurinol...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1002/phar.1943

    authors: Carr CN,Straley CM,Baugh TB

    更新日期:2017-06-01 00:00:00

  • Clinical and microbiologic analysis of a hospital's extended-spectrum beta-lactamase-producing isolates over a 2-year period.

    abstract:STUDY OBJECTIVE:To evaluate the microbiologic and clinical outcomes of patients with extended-spectrum beta-lactamase (ESBL)-producing isolates over a 2-year period. DESIGN:Retrospective analysis. SETTING:Tertiary care teaching hospital. PATIENTS:Twenty-one patients with cultures of confirmed ESBL-producing Escheric...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.23.12.1232.32706

    authors: Burgess DS,Hall RG 2nd,Lewis JS 2nd,Jorgensen JH,Patterson JE

    更新日期:2003-10-01 00:00:00

  • The use of aztreonam in pediatric patients: a review.

    abstract::Aztreonam is the first monobactam available for use in this country. A parenteral antibiotic, its antibacterial spectrum is limited to gram-negative aerobic pathogens. The drug's pharmacologic, pharmacokinetic, and toxicologic properties are reviewed. Based on early experience in pediatric patients, certain recommenda...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:

    authors: Bosso JA,Black PG

    更新日期:1991-01-01 00:00:00

  • Antidepressants in the management of chronic pain syndromes.

    abstract::Conditions in which antidepressants have been used include diabetic neuropathy, postherpetic neuralgia, headaches, arthritis, chronic back pain, cancer, thalamic pain, facial pain, and phantom limb pain. Although much of the available information is derived from inadequately controlled trials, it seems that antidepres...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:

    authors: Egbunike IG,Chaffee BJ

    更新日期:1990-01-01 00:00:00

  • Predictors of a Response to Dexmedetomidine in Intubated, Critically Ill Adult Patients.

    abstract:BACKGROUND:Dexmedetomidine is a centrally acting α-2 receptor agonist used to maintain light analgosedation in mechanically ventilated adults. This study was conducted to determine factors predictive of successful maintenance of light sedation (Richmond Agitation-Sedation Scale (RASS) 0 to -2) for ≥60% of the first 48 ...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1002/phar.2501

    authors: DiCesare MA,Rech MA,DeMott JM

    更新日期:2021-01-09 00:00:00

  • Discontinuation of antihypertensive drugs due to adverse events: a systematic review and meta-analysis.

    abstract::We conducted a systematic review of randomized, controlled, monotherapy trials since 1990 of oral antihypertensive agents in patients with essential hypertension. Our objective was to quantify the frequency of discontinuation of antihypertensive agents due to adverse events from a meta-analysis of the studies. A total...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,meta分析

    doi:10.1592/phco.21.11.940.34520

    authors: Ross SD,Akhras KS,Zhang S,Rozinsky M,Nalysnyk L

    更新日期:2001-08-01 00:00:00

  • Does the addition of pindolol accelerate or enhance the response to selective serotonin reuptake inhibitor antidepressants?

    abstract::Although in the last few years new antidepressants have become available in the United States, responses in many patients differ, from none, to partial, to delayed therapeutic response to the agents. If the antidepressant properties of these drugs could be enhanced or accelerated, it might be possible to improve patie...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1592/phco.19.3.205.30921

    authors: Puzantian T,Kawase K

    更新日期:1999-02-01 00:00:00

  • Piperacillin-tazobactam pharmacokinetics in patients with intraabdominal infections.

    abstract:STUDY OBJECTIVE:To determine the appropriate compartmental and noncompartmental pharmacokinetic parameters for intravenous piperacillin and tazobactam. DESIGN:Sequential selection of patients entered into a randomized, open-label clinical efficacy trial. SETTING:Los Angeles County-University of Southern California Me...

    journal_title:Pharmacotherapy

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:

    authors: Jhee SS,Kern JW,Burm JP,Yellin AE,Gill MA

    更新日期:1995-07-01 00:00:00

  • Acute Graft-versus-Host Disease: Emerging Insights and Updates into Detection, Prevention, and Treatment.

    abstract::Acute graft-versus-host disease remains a devastating complication following hematopoietic cell transplantation, resulting in increased morbidity and mortality. Vast research efforts continue to refine or develop new means of prediction, assessment, prevention, and treatment of this syndrome. Recent updates in acute g...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1002/phar.2436

    authors: DiMaggio E

    更新日期:2020-08-01 00:00:00

  • Cerivastatin-induced rhabdomyolysis: 11 case reports.

    abstract::3-Hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors are a frequently prescribed class of drugs that are generally well tolerated by most patients. A rare, yet serious side effect associated with these drugs is rhabdomyolysis. Although all HMG-CoA reductase inhibitors can cause this adverse effect, pre...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1592/phco.22.7.533.33674

    authors: Ravnan SL,Locke C,Yee WP,Haase K

    更新日期:2002-04-01 00:00:00

  • Management of and counseling for psychotropic drug-induced sexual dysfunction.

    abstract::Clinicians are increasingly faced with the need to identify, treat, and counsel patients regarding psychotropic drug-induced sexual dysfunction. Antipsychotic and antidepressant drugs have both rational mechanisms to explain their effects on sexual function and established literature documenting these effects. The age...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1592/phco.19.10.823.31553

    authors: Gutierrez MA,Stimmel GL

    更新日期:1999-07-01 00:00:00

  • Medication Management of Patients Undergoing Transcatheter Aortic Valve Replacement.

    abstract::Aortic stenosis (AS) is the most common form of valvular heart disease. A detailed diagnostic workup is necessary to promptly stage and classify disease severity to determine optimal management. Medical therapy and valvuloplasty are options that fail to delay or reverse disease progression. Surgical aortic valve repla...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1002/phar.2056

    authors: Kalich BA,Allender JE,Hollis IB

    更新日期:2018-01-01 00:00:00